BAXTER INTERNATIONAL INC — Form 10-Q
Filed October 29, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 28/100
What the filing says
John Rogers appointed Executive Vice President and Chief Financial Officer effective October 1, 2026, under a UK employment contract (Baxter Healthcare Limited) pending US work authorization. Compensation: £683,085 (~USD 925,000) annual salary plus 100% bonus target (pro-rated for 2026), eligible for equity grants and sign-on bonus per his August 18, 2026 US offer letter. Standard executive benefits include pension, life insurance (4x salary), private medical cover, and severance protections under Baxter's Executive Severance and Change in Control Plan.
Why this rating
CFO appointment is routine executive hiring. Compensation USD ~925k salary + bonus is ~0.006% of $16B market cap—immaterial. No operational, financial, or strategic change disclosed.
See more from October 29, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.